Search Results
Aug 13, 2026, 08:30 ET AI-Enabled Pharmacovigilance: Practical Strategies for Smarter Safety Operations, Upcoming Webinar Hosted by Xtalks
considerations, and understand the principles needed to maintain patient safety, regulatory compliance, and human accountability.Join Ian Kovacs, PhD, Global Head of Pharmacovigilance,
More news about: Xtalks
Aug 13, 2026, 08:30 ET CMC Strategy in Biologics: Decisions With Downstream Consequences, Upcoming Webinar Hosted by Xtalks
Register for this webinar to learn how CMC strategy can reduce costly rework, development delays and manufacturing risk.Join Xiao-Ping Dai, PhD, Chief Technical Officer, Alveus Therapeutics; and Dr. Ellen Hilgenberg, Director, Business Development,
More news about: Xtalks
Aug 12, 2026, 09:10 ET Quantinuum et Oracle s'associent pour accélérer l'adoption de l'informatique quantique hybride sur Oracle Cloud Infrastructure
ressources quantiques et de les intégrer est devenu tout aussi important que de faire progresser le matériel lui-même », a déclaré Heather West, PhD, responsable mondiale de la recherche sur l'informatique quantique chez IDC. « Le déploiement de systèmes quantiques au sein d'environnements de
More news about: Quantinuum
Aug 12, 2026, 09:00 ET Cellular Intelligence Names Single-Cell Biology Pioneer Arjun Raj, Ph.D., Chief Scientific Officer and Scientific Co-Founder
multimedia:https://www.prnewswire.com/news-releases/cellular-intelligence-names-single-cell-biology-pioneer-arjun-raj-phd-chief-scientific-officer-and-scientific-co-founder-302849016.htmlSOURCE
More news about: Cellular Intelligence
Aug 12, 2026, 08:30 ET Challenges and Opportunities in Real-Time Clinical Trials, Upcoming Webinar Hosted by Xtalks
Managing Partner, Heinsight; (Panelist) Jay Herson, PhD, Senior Associate, Biostatistics, Johns Hopkins Bloomberg School of Public Health; (Panelist) Scott Proestel, MD, Principal, Bethesda Pharmaceutical Consulting, LLC; and (Panelist) Greg Ball, PhD, Safety Data Scientist, ASAPprocess Consulting, for
More news about: Xtalks
Aug 12, 2026, 08:30 ET Improve Drug Solubility from Formulation to Scale-Up, Upcoming Webinar Presented by Quotient Sciences and NGT Biopharma Consultants, Hosted by Xtalks
Quotient Sciences; Mark A. Krook, PhD, CMC & Early Drug Development, NGT Biopharma Consultants; and Andrew Parker, PhD, Executive Drug Development Consultant, Quotient Sciences, as they explore how a connected development strategy
More news about: Xtalks
Aug 12, 2026, 08:30 ET Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
pipeline, combining a novel AI-enabled structure with strong preclinical data in potency, selectivity, safety, and oral pharmacokinetics," said Feng Ren, PhD, Co-CEO and Chief Scientific Officer of Insilico Medicine. "More importantly, the formation as an oral therapy may also offer important advantages
More news about: Insilico Medicine
Aug 12, 2026, 08:30 ET Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease
development, expected to commence in Q4, 2026. Hybridopa is an investigational product and has not yet been approved by the FDA.Michal Tsur, PhD, and Or Shoval, Co-CEOs of Remepy, "We believe medicine is entering a new era, where every breakthrough drug will be paired with personalized intelligence
More news about: Remepy
Aug 12, 2026, 08:09 ET Iterion Therapeutics Strengthens Board with Additions of Manuel Aivado, MD, PhD and Bob Smith
first-in-class therapies targeting aberrant Wnt/β-catenin signaling, today announced the addition of two new Independent Board Members, Manuel Aivado, MD, PhD and Bob Smith.
More news about: Iterion Therapeutics
Aug 12, 2026, 08:00 ET Ochsner Health and Paradigm Health expand access to clinical trials across the Gulf South
trials as a care option.""Our partnership with Paradigm Health marks a fundamental shift in how we approach clinical research," said Wendy Chriss, PhD, director of clinical research at Ochsner Health. "By automating the incredibly complex, manual screening process, we are making clinical trials an inclusive,
More news about: Paradigm Health, Inc.
Aug 12, 2026, 07:00 ET Insurify Names Former KAYAK AI Leader Jake Bouvrie as Its First Chief AI Officer
Head of AI and Data Science at Gradient AI, developing machine learning products for insurance underwriting and risk analytics.Bouvrie holds a PhD from MIT's Department of Brain and Cognitive Sciences, where he trained under Professor Tomaso Poggio, a founder of computational neuroscience and an
More news about: INSURIFY, Inc.
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
response rates and survival with sirexatamab, making a compelling case for a biomarker-selected Phase 3 registrational trial," said Markus Moehler, MD, PhD, Head of GI Oncology, Senior Physician Gastroenterology & Endosonography Head at the Mainz University Clinic.Key Findings from the PublicationDeFianCe
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 06:30 ET Boulevard Bio Launches with $65 Million from Deerfield and World-Class Founders to Advance Precision Immunology Pipeline
Brian Chow, PhD, Managing Director at Deerfield Management; Deerfield Partner and 3DC CEO Frank Nestle, MD, is scientific co-founder and serves on the board. Boulevard was co-founded by Prof. Georg Schett, MD, a pioneer in immune reset, alongside founding advisor Prof. Jonathan Barratt, PhD, FRCP. Boulevard
More news about: Boulevard Bio
Aug 12, 2026, 06:00 ET Function Announces Partnership with NYU Grossman School of Medicine to Launch Landmark Research Aimed at Advancing Earlier Disease Detection
our best tools last. We typically deploy advanced imaging and/or blood testing only after people are already sick," said Daniel K. Sodickson, M.D., PhD, Chief Medical Scientist at Function and former Chief of Innovation in Radiology at NYU Langone Health. "This partnership flips that script. By pairing
More news about: Function Health
Aug 12, 2026, 05:25 ET Beyang Closes Oversubscribed $30 Million Series A Financing
the biomedical sector to support the innovation and development of the global biopharmaceutical industry.Contact:Minghui Tong, PhDBeyang [email protected] +86-13265738517
More news about: Beyang Therapeutics Co., Ltd.
Aug 12, 2026, 05:07 ET Quantinuum e Oracle firmam parceria para acelerar a adoção da computação quântica híbrida na infraestrutura de nuvem da Oracle
forma como as empresas acessam e integram os recursos quânticos tornou-se tão importante quanto o avanço do próprio hardware", disse Heather West, PhD, líder global de Pesquisa Quântica da IDC. "A implantação de sistemas quânticos em ambientes de nuvem privada permite que as empresas integrem a
More news about: Quantinuum
Aug 11, 2026, 16:01 ET Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure
simplifying how organizations access and integrate quantum resources has become just as important as advancing the hardware itself," said Heather West, PhD, Global Quantum Research Lead at IDC. "Deploying quantum systems within private cloud environments enables organizations to integrate quantum computing
More news about: Quantinuum
Aug 11, 2026, 16:01 ET Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure
simplifying how organizations access and integrate quantum resources has become just as important as advancing the hardware itself," said Heather West, PhD, Global Quantum Research Lead at IDC. "Deploying quantum systems within private cloud environments enables organizations to integrate quantum computing
More news about: Quantinuum
Aug 11, 2026, 11:42 ET From Data Burden to Breakthrough Engine: The Expanding Value of Standards, Upcoming Webinar Hosted by Xtalks
interoperability, strengthen AI outputs and accelerate research readiness.Join Rebecca Daniels Kush, PhD, President of Catalysis and Founder and President Emeritus of CDISC; Ron Fitzmartin, PhD, MBA, Principal Consultant, Decision Analytics LLC; Aaron Mann, Chief Executive Officer, Clinical Research
More news about: Xtalks
Aug 11, 2026, 09:00 ET EIT Pharma Announces FDA Acceptance of New Drug Application for Lonafarnib for Treatment of Chronic Hepatitis D
NDA is an important milestone in our mission to bring a potential new oral treatment to people living with chronic hepatitis D," said Dr. Leen Kawas, PhD, Chief Executive Officer of EIT Pharma. "We're grateful to the patients, investigators, and researchers whose commitment to the D-LIVR study made this
More news about: EIT Pharma
Aug 11, 2026, 08:58 ET Stand Up To Cancer Nicolai Award Will Fund KRAS-Targeted Immunotherapy Combination for Pancreatic Cancer
The collaborative project is being led by Eric Tran, PhD, of the Providence Cancer Institute, Portland, OR, and Di Liu, PhD, of Arizona State University, Tempe, AZ. Dr. Tran leads the Adoptive Cell Therapy Laboratory in Providence's Earle A.
More news about: Stand Up To Cancer, a division of the Entertainment Industry Foundation
Aug 11, 2026, 08:20 ET Americans Know How to Manage Money. Why Can't They Make Good Financial Practices Stick?
delinquency rates remain elevated. "America doesn't just have a financial literacy gap, it has a financial behavior gap," said Dr. Erika Rasure, PhD, CFT™, chief financial wellness advisor at Beyond Finance and creator of the
More news about: Beyond Finance
Aug 11, 2026, 07:10 ET Sciton Marks Fourth Inc. 5000 Recognition, Reinforcing Its Leadership in Medical Aesthetics
Palo Alto, California, is a forward-thinking, employee-owned medical device company founded in 1997 by industry visionaries James Hobart, PhD, and Daniel K. Negus, PhD. Renowned for delivering high-quality laser and light solutions, Sciton's product portfolio spans a broad range of medical and aesthetic
More news about: Sciton
Aug 11, 2026, 07:00 ET Transpire Bio's Dr. Lei Mao Appointed as Board Chair of the IPAC-RS for its 2026-2028 Term
clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, last week announced that Lei Mao, PhD, Transpire Bio's Head of External Research, has been elected to the position of Board Chair of the International Pharmaceutical Aerosol Consortium on
More news about: Transpire Bio
Aug 11, 2026, 07:00 ET Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
patients."Vaderis has generated compelling clinical evidence supporting targeted AKT inhibition as a novel treatment approach for HHT," said Colin Walsh, PhD, Managing Director, Life Sciences at Goldman Sachs Alternatives. "The company's strong scientific foundation, disciplined execution and clear focus on
More news about: Vaderis Therapeutics AG